Long‐term benefits of nusinersen in a child affected by cystic fibrosis and spinal muscular atrophy type 1
Keyword(s):
2016 ◽
Vol 101
(Suppl 1)
◽
pp. A74.1-A74
2007 ◽
Vol 43
(4)
◽
pp. 237-242
◽
2018 ◽
2019 ◽